Placebo-controlled trial of risperidone augmentation for SSRI [selective serotonin reuptake inhibitor]-resistant civilian PTSD [post-traumatic stress disorder]
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Risperidone (Primary) ; Sertraline
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 08 Jan 2007 Status change
- 03 Dec 2005 New trial record.